Who can join
Studies for children and teens
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
468 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism
Blinklab Limited
- Location
- Princeton, NJ
- Eligibility basics
- Ages 2–11
- RecruitingHealthy volunteers
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
NeurOptics Inc
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 3–17
- RecruitingHealthy volunteers
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
SightGlass Vision, Inc.
- Location
- Glendale, AZ
- Eligibility basics
- Ages 6–12
- RecruitingHealthy volunteers
Children's Viewing Behavior
SightGlass Vision, Inc.
- Location
- Bloomington, IN
- Eligibility basics
- Ages 7–14
- RecruitingHealthy volunteers
Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma
Medentum Innovations
- Location
- Tuscon, AZ
- Eligibility basics
- Ages 3–17
- RecruitingHealthy volunteers
Flourish: Exploring the Early Infant Gut Microbiome
Seeding Inc
- Location
- Austin, TX
- Eligibility basics
- Ages 0 mo–4 mo
- RecruitingHealthy volunteers
Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers
Owlet Baby Care, Inc.
- Location
- San Francisco, CA
- Eligibility basics
- Ages 1–5
- RecruitingHealthy volunteers
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
SightGlass Vision, Inc.
- Location
- Oakland, CA + 13 other US sites
- Eligibility basics
- Ages 6–8
- RecruitingHealthy volunteers
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
Thrive Neuromedical, LLC
- Location
- Atlanta, GA
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingHealthy volunteers
Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).
Myo Munchee (Operations) Pty Ltd
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 3–5
- RecruitingHealthy volunteers
NeuroTrainer Cognitive Training For Academic Focus
NeuroTrainer
- Location
- Marquette, MI + 2 other US sites
- Eligibility basics
- Ages 11–17
- RecruitingHealthy volunteers
Parent-Child EF Intervention
Koronis Biomedical Technologies
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 2–5
- RecruitingHealthy volunteers
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
MindTension
- Location
- New York, NY
- Eligibility basics
- Ages 6–17
- RecruitingHealthy volunteersPhase 3
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
ARJ Medical, Inc.
- Location
- Doral, FL + 2 other US sites
- Eligibility basics
- Ages 3–17
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- San Francisco, CA + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Hoffmann-La Roche
- Location
- Birmingham, AL + 10 other US sites
- Eligibility basics
- Ages 1 mo–11
- RecruitingPhase 3
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
PTC Therapeutics
- Location
- Indianapolis, IN
- Eligibility basics
- Up to age 9
- RecruitingPhase 2
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Amgen
- Location
- Chicago, IL + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Biogen
- Location
- Chicago, IL + 2 other US sites
- Eligibility basics
- Ages 0 mo–1 mo
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
AbbVie
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Fresenius Kabi
- Location
- Atlanta, GA + 3 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 3
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Amicus Therapeutics
- Location
- Atlanta, GA + 5 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
AbbVie
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2/Phase 3
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
BioMarin Pharmaceutical
- Location
- Oakland, CA + 7 other US sites
- Eligibility basics
- Ages 2–17
Questions
If I fit this group, will I qualify?
Not necessarily. Age and sex limits are only the first filter. Each study has its own inclusion and exclusion criteria, and the research team decides at screening.
Where do these age and sex limits come from?
From the eligibility section of each study’s official ClinicalTrials.gov record. We don’t infer eligibility from anything else.